Antimicrobial susceptibilities of Campylobacter strains isolated from Finnish subjects infected domestically or from those infected abroad

被引:18
作者
Rautelin, H
Vierikko, A
Hänninen, ML
Vaara, M
机构
[1] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Diagnost Lab, FIN-00014 Helsinki, Finland
[3] Univ Helsinki, Dept Food & Environm Hyg, FIN-00014 Helsinki, Finland
关键词
D O I
10.1128/AAC.47.1.102-105.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The in vitro susceptibilities of 678 Campylobacter jejuni and Campylobacter coli strains isolated from stool samples of the same number of Finnish subjects were studied. A total of 523 patients, representing inhabitants from throughout Finland, had not traveled abroad within the 2 weeks prior to becoming ill, whereas 155 persons had presumably acquired their infections abroad. The antimicrobial agents studied were erythromycin, ciprofloxacin, levofloxacin, trovafloxacin, and moxifloxacin. The MICs of these antimicrobial agents were determined by the agar dilution method. The growth of all domestic isolates was inhibited by erythromycin at concentrations of 4 mug/ml, and for these isolates the fluoroquinolone MICs at which 90% of isolates are inhibited (MIC(90)s) ranged from 0.06 to 0.5 mug/ml. For the foreign isolates, the erythromycin MIC90 was still low (4 mug/ml), but their susceptibilities to fluoroquinolones were clearly reduced (MIC90s, 8 to 64 mug/ml). Of the four different fluoroquinolones studied, ciprofloxacin was the least active (MIC90, 64 mug/ml).
引用
收藏
页码:102 / 105
页数:4
相关论文
共 27 条
[1]   Empirical antimicrobial therapy for traveler's diarrhea [J].
Adachi, JA ;
Ostrosky-Zeichner, L ;
DuPont, HL ;
Ericsson, CD .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (04) :1079-1083
[2]   Tentative minimum inhibitory concentration and zone diameter breakpoints for moxifloxacin using BSAC criteria [J].
Andrews, JM ;
Ashby, JP ;
Jevons, GM ;
Wise, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (06) :819-822
[3]   QUINOLONE RESISTANCE IN CAMPYLOBACTER ISOLATED FROM MAN AND POULTRY FOLLOWING THE INTRODUCTION OF FLUOROQUINOLONES IN VETERINARY-MEDICINE [J].
ENDTZ, HP ;
RUIJS, GJ ;
VANKLINGEREN, B ;
JANSEN, WH ;
VANDERREYDEN, T ;
MOUTON, RP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (02) :199-208
[4]  
Friedman C.R., 2000, CAMPYLOBACTER, V2nd, P121
[5]   In vitro activity of trovafloxacin against ciprofloxacin-susceptible and -resistant clinical bacterial isolates and assessment of the trovafloxacin disk test [J].
Fuchs, PC ;
Barry, AL ;
Brown, SD .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 33 (01) :33-38
[6]   Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada [J].
Gaudreau, C ;
Gilbert, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :2106-2108
[7]   SUSCEPTIBILITIES OF FLUOROQUINOLONE-RESISTANT STRAINS OF CAMPYLOBACTER-JEJUNI TO 11 ORAL ANTIMICROBIAL AGENTS [J].
GOMEZGARCES, JL ;
COGOLLOS, R ;
ALOS, JI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :542-544
[8]  
Hänninen ML, 1998, J CLIN MICROBIOL, V36, P1787
[9]   THE INDUCTION OF QUINOLONE RESISTANCE IN CAMPYLOBACTER BACTERIA IN BROILERS BY QUINOLONE TREATMENT [J].
JACOBSREITSMA, WF ;
KAN, CA ;
BOLDER, NM .
LETTERS IN APPLIED MICROBIOLOGY, 1994, 19 (04) :228-231
[10]  
Jorgenson J. H., 1999, MANUAL CLIN MICROBIO, P1526